CKD-843
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 08, 2025
A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
(clinicaltrials.gov)
- P3 | N=288 | Not yet recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P3 trial • Alopecia • Dermatology • Immunology
January 22, 2024
The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A
(clinicaltrials.gov)
- P1 | N=41 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Not yet recruiting ➔ Completed
Trial completion • Alopecia • Immunology
October 20, 2022
The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A
(clinicaltrials.gov)
- P1 | N=40 | Not yet recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial • Alopecia
1 to 3
Of
3
Go to page
1